Emvision Medical Devices (ASX:EMV)
ASX announcement history & article coverage
Transparent by design.
Announcments by Emvision Medical Devices (ASX:EMV) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Mayo Clinic emu Early Clinical Experience Presentation
Date of AGM & Closing Date of Director Nominations
$4.3m Non-Dilutive R&D Tax Rebate Received
EMVision receives $4.3 million R&D tax refund to support medical device development
First Responder Successfully Trialled with MSU
EMVision completes mobile stroke scanner feasibility study and signs funding MoU
Notification regarding unquoted securities - EMV
emu Regional Benefits Study Advancing
EMVision advances regional stroke diagnosis study with CRC-P funding and site visits complete
emu Pivotal Trial Recruitment Surpasses 200 Patients
EMVision surpasses 200 patients in emu™ brain scanner pivotal trial, advancing FDA clearance pathway
FY26 Results Presentation
Appendix 4G & Corporate Governance Statement
Appendix 4E & Annual Report to 30 June 2026
EMVision reports FY26 progress with increased revenue, reduced loss, and advances in brain scanner trials
Change of Registered Office Address